Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Moodys
Medtronic
Colorcon
AstraZeneca

Drugs facing the most patent expirations this year

Expiring drug patents are continuously driving innovation, as branded firms seek out new high-margin opportunities.

Examining the patent expirations by year can indicate which pharmaceutical companies face the most peril from loss of patent protection.

This chart shows which pharmaceutical companies face the most patent expirations this year.

The drug companies facing the most patent expirations this year are:

Back to Pharmaceutical Industry Infographics

Make Better Decisions: Try a trial or see plans & pricing